The Endometrial Cycle

Abstract Aims and Objectives: To evaluate the role of endometrial thickness, pattern and sub-endometrial blood flows measured by 2D power Doppler ultrasound to predict pregnancy during in-vitro fertilization IVF treatment. Prospective, non-randomized clinical study. This was a prospective observational study. Women with tubal factor, male factor and unexplained infertility were included in the study.

The mean age was 35 years and mean duration of infertility was 8 years.

gratis dating-nettsteder åndelige internasjonale online dating nettsteder skrive epost til dating-nettsteder noyes kriterier endometrial dating dyret jeg en mann enkelt yngre gutta dating cougars debatten ng iglesia på dating daan.

Provisional Patent Application No. What is claimed is: The method of claim 1, wherein the presence of NCSs indicates that the endometrium is in a state that is receptive for implantation of an embryo. The method of claim 1, wherein the tissue sample is obtained from the endometrium of a woman between day 18 and day 24 of a 28 day menstrual cycle, where day 1 of the cycle is defined as the first day of menstrual blood loss, and wherein the absence of NCSs indicates that the endometrium is not in a state that is receptive for implantation of an embryo.

The method of claim 1, wherein the tissue sample is obtained from the endometrium of a woman between day 19 and day 22 of a 28 day menstrual cycle, where day 1 of the cycle is defined as the first day of menstrual blood loss, and wherein the absence of NCSs indicates that the endometrium is not in a state that is receptive for implantation of an embryo.

The method of claim 1, wherein the tissue sample is obtained from the endometrium of a woman between day 4 and day 9 of the luteal phase of the menstrual cycle, and wherein the absence of NCSs indicates that the endometrium is not in a state that is receptive for implantation of an embryo. The method of claim 1, wherein the tissue sample is obtained from the endometrium of a woman between day 5 and day 8 of the luteal phase of the menstrual cycle, and wherein the absence of NCSs indicates that the endometrium is not in a state that is receptive for implantation of an embryo.

The method of claim 1, wherein the presence or absence of the protein is determined using a light microscope. The method of claim 9, wherein the tissue sample is obtained from the endometrium of a woman between day 18 and day 24 of a 28 day menstrual cycle, where day 1 of the cycle is defined as the first day of menstrual blood loss. The method of claim 9, wherein the tissue sample is obtained from the endometrium of a woman between day 19 and day 22 of a 28 day menstrual cycle, where day 1 of the cycle is defined as the first day of menstrual blood loss.

The method of claim 9, wherein the presence of NCSs is detected between day 18 and day 24 of a 28 day menstrual cycle, where day 1 of the cycle is defined as the first day of menstrual blood loss. The method of claim 9, wherein the presence of NCSs is detected between day 19 and day 22 of a 28 day menstrual cycle, where day 1 of the cycle is defined as the first day of menstrual blood loss. The method of claim 9, wherein the presence of NCSs is detected between day 4 and day 9 of the luteal phase of the menstrual cycle.